Goring, S., Scott, D., Briggs, A., Penrod, J., Wilson, J., Waser, N., . . . Yuan, Y. (2016). PRM2 - Considerations in Meta-Analytic Network Design: The Case of Platinum Doublet Chemotherapies in Advanced Non-Small Cell Lung Cancer (Advnsclc). Value in Health, 19(7), A357. https://doi.org/10.1016/j.jval.2016.09.065
Chicago Style (17th ed.) CitationGoring, SM, et al. "PRM2 - Considerations in Meta-Analytic Network Design: The Case of Platinum Doublet Chemotherapies in Advanced Non-Small Cell Lung Cancer (Advnsclc)." Value in Health 19, no. 7 (2016): A357. https://doi.org/10.1016/j.jval.2016.09.065.
MLA (9th ed.) CitationGoring, SM, et al. "PRM2 - Considerations in Meta-Analytic Network Design: The Case of Platinum Doublet Chemotherapies in Advanced Non-Small Cell Lung Cancer (Advnsclc)." Value in Health, vol. 19, no. 7, 2016, p. A357, https://doi.org/10.1016/j.jval.2016.09.065.